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Introduction 
Propane-1,2,3-triol is a widely occurring substance and is better known by its trivial names 
glycerol or glycerin(e). The most important natural source is in lipids. It is present in some 
types of explosives and cosmetics. From the field of food-chemistry, glycerol can be 
categorized as a sugar-alcohol (poly-ol) because each carbon bears a hydroxyl-function and 
has a sweet taste [1]. Therefore it is used as an additive (E422) to sweeten and to preserve 
food. Nevertheless, overdosing glycerol can cause headaches, dizziness, thirst, and diarrhea. 
Some sources report it can be used in the treatment of bacterial meningitis [2], in Menière 
disease (diagnostic agent) [3], stroke [4] or brain edema [5]. Unfortunately, convincing 
evidence for a benefit of these applications is missing. A more common use in the field of 
medicine is the application as lubricant, additive for medication and as laxativum. 
Like other products, glycerol triggered attention from athletes or their physicians for its 
capability to hyper-hydrate which might yield an ergogenic effect. However scientific 
research showed controversial results regarding its ergogenic potency [6-12].. Another reason 
why athletes might use glycerol is for its capability to retain water which can result in a 
reduced hematocrit-value [14,15]. But these effects are also limited. Nevertheless, glycerol 
was included in the WADA-prohibited list from January 2012 on with a threshold of 1.3 
mg/mL[16]. In September 2013, the threshold was further increased to 4.3 mg/mL (Decision 
limit (DL) 5.3 mg/mL) [17] because research has shown that the previous threshold might 
yield false positive findings [18]. Because of the aforementioned questionable and moderate 
benefits of glycerol, it was not expected to have an Adverse Analytical Finding (AAF). 
However, recently a routine doping sample in our laboratory was found to contain glycerol in 
concentrations higher than the decision limit. This application note describes the screening by 
LC-HRMS and confirmation by a GC-EI-MS method.  
Materials and methods 
Chemicals and reagents 
All the reagents were analytical or HPLC grade. Reference standard of glycerol 
(electrophoresis-grade) and internal standard (ISTD) glycerol-d5 were purchased from Sigma-
Aldrich (Bornem, Belgium). Beta-glucuronidase (containing aryl-sulphatase activity) from 
Helix Pomatia (HP) was from Roche (Mannheim, Germany). Buffer pH 5.2 was obtained by 
dissolving 136 g sodium acetate (NaOAc) (Merck, Darmstadt, Germany) into 800 mL of 
double-distilled water. The pH was adjusted to 5.2 by adding acetic acid (HOAc) (Merck). 
Then the final volume was made to 1 L. Buffer pH 9.5 was prepared by dissolving 45 g 
potassium carbonate (K2CO3)(Merck) and 37 g sodium hydrogencarbonate (NaHCO3)(Merck) 
in 300 mL of H2O. Formic acid (HCOOH) (99%) and ammonium formiate (NH4OOCH) were 
from Fisher-Scientific (Aalst, Belgium). Water and acetonitrile (ACN) were obtained from 
J.T. Baker-Avantor (Deventer, The Netherlands). tert-butyl methyl ether (TBME) for 
extraction was from Macron-Avantor (Deventer). N-Methyl-N-
(trimethylsilyl)trifluoroacetamide (MSTFA) was obtained from Karl-Bucher GMBH 
(Waldstetten, Germany). 
 
Screening (LC-HRMS) 
To 50 µL of urine, 450 µL of dilution-solution is added. The dilution solution is composed of 
95/5 (H2O/ACN) containing 0.01% HCOOH/1mM NH4OOCH and glycerol-d5 (300 µg/mL). 
Finally, the sample is centrifuged 5 min. at 7900 RCF. Meanwhile, to 3 mL of the same urine, 
50 µL beta-glucuronidase and 1 mL of the acetate-buffer pH 5.2 is added. The sample is 
hydrolysed for 1h at 56°C. After adding 1 mL of the buffer (pH 9.5 and 5 mL of TBME, the 
sample is extracted for 20 min  on a CAT RM5-roller (Staufen, Germany). After extraction, 
the sample is centrifuged 5 min at 600 RCF. Then, the organic layer is transferred to a 
separate tube and is evaporated under oxygen free nitrogen (OFN). 200 µL of the dilute-and-
shoot fraction was added to the dried residue. 
Analysis is done on a Thermo Exactive-system. Chromatography is performed on a Surveyor 
(pump/autosampler)-system equipped with a Zorbax-RX C8 column (50mm, ID= 2 mm, 
particle size 1,8 µm). A: H2O (0,01% NH4OAc, 1mM NH4OOCH)/ B: ACN (0,01% 
HCOOH). The solvent program was as follows: 0.0 - 0.5 min: isocratic 100 % A; 0.5 - 7.5 
min: decrease to 20 % A; 7.5 – 8.0 min: decrease to 0 % A; 8.0 - 9.5 min: isocratic 0 % A; 9.5 
– 9.6 min: increase to 100 % A; 9.6 - 12 min: isocratic 100% A. Flow-rate is 0.250 µL/min, 
injection volume 20 µL. ESI (3 kV) ,Sheath gas: 50, aux gas: 20/ Capillary temperature: 
350°C; Capillary voltage 30 V or -25 V(pos/ neg-mode respectively). 4 experiments are 
acquired simultaneously: Full scan MS+, Full scan MS-, all ion fragmentation (HCD), Full 
scan MS+, in source CID (80 eV), Full scan MS+. Glycerol and glycerol-d5 are detected in 
the  Full scan MS+ by monitoring respectively m/z 115.03650 [glycerol+Na]+ and [glycerol-
d5+Na]+ m/z 120.06790 with a mass window of 5 ppm. 
 
Confirmation (GC-MS) 
The confirmation was performed with a validated GC-MS method. A 6-point calibration 
curve spiked at 1.25; 2.5 4.5; 6; 8; 10 mg/mL and quality control sample was co-analysed 
with the suspicious sample. Sample preparation is as follows: To 200 µL of urine, 25 µL IL-
ISTD-solution (10 mg/mL glycerol-d5) and 5 mL TBME is added followed by a liquid-liquid 
extraction for 20 minutes by rolling Then, the organic phase was evaporated under OFN. 100 
µL MSTFA was added to the dried sample. Derivatization time was 10 min at 80°C +/- 5°C. 
Analysis was done on an Agilent GC-MSD (HP6890) in full scan MS: scan range m/z 50-800, 
Injection mode: Splitless (0.2µL)/ Column: 15 m, HP-5MS (0.25 mm; 0,25 µm), carrier gas: 
Helium. Oven program: 0-0.5 min:  90°C; 0.5-4.1 min: linear increase to 108°C; 4.1-4.7 min:  
108°C; 4.7-7.5 min: linear increase to 320°C; 7.5-8.78 min: 320°C. Flow program: 0-4 min: 1 
mL/min; 4-6 min: linear increase to 2 mL/min. The  ions used for quantitation are m/z  205 for 
glycerol and m/z 208 for glycerol-d5. The additional ions used for qualitative purposes are m/z 
218, 103, 117, 133, 175 for glycerol and m/z 222, 298 for glycerol-d5 
 
Results and discussion 
Screening 
Both GC-MS and LC-MS are the standard screening-techniques for small molecules (< 1,000 
Da) in the field of anti-doping analysis. Papers describing glycerol detection by GC-MS are 
ubiquitous [13,19-23]. Hence the first idea was to screen for glycerol by this latter technique 
by incorporating glycerol into a GC-MS method used for the detection of anabolic 
steroids[24]. Unfortunately, initial tests show an interfering peak in blank urine as well as in 
the blank control sample (H2O). Hence, it was concluded that the background originated from 
one of the reagents. Indeed, glycerol was found to be present as a stabilizing agent in the 
liquid beta-glucuronidase (BG) preparations from E.Coli, independent from the brand. 
Unfortunately, this enzyme can’t be replaced because it is the only enzyme permitted to be 
used for the analysis of endogenous anabolic steroids (AAS) in combination which GC-MS 
[25]. If screening by GC-MS would need to be performed, a separate (extra) method –without 
hydrolysis- would be needed. Instead, it was considered to include this substance into the LC-
HRMS screening method. Indeed, previous research has shown that glycerol can be detected 
by LC-MS by monitoring the metal adducts [M+Cs]+ [26] or [M+Na]+ [27]. Based upon these 
findings a method consisting of a simple 10-fold dilution step of the urines followed by 
injection into the LC-HRMS method was developed in our laboratory [28] following a so 
called dilute-and-shoot strategy (DS-LC-MS) [29]. Recently, a similar detection strategy was 
developed by Gorgens et al. [30]. 
Because the 10-fold diluted urine from the original method [28] is currently used to 
reconstitute the dried extract (see experimental section) the glycerol from the BG from E. Coli 
would also interfere. Therefore several other lyophilised BG-preparations from E. Coli. were 
evaluated. Beside the high price, the activity (measured against androsterone-glucuronide, 
results not shown) was poor compared to readily dissolved BG-preparations from E. Coli. 
Finally, liquid BG from Helix Pomatia -not containing glycerol- was incorporated in the 
sample preparation showing good activity . 
Due to the polar nature of glycerol, chromatographic retention is limited (k = 0,2). Therefore, 
the use of an IL-ISTD was considered to be mandatory. However, spiking glycerol-d5 in the 
same concentration range of the target compound (> mg/mL range), was deemed 
economically unacceptable. Therefore, the IL-ISTD was only added to the dilute-and-shoot-
fraction of the method. 
The semi-quantitative detection in the screening (1 point curve, forced through zero) was 
validated by analysing 11 samples (10 urines + H2O) spiked with glycerol at 3 mg/mL. 
Calculating the detected concentrations against the water sample allowed to evaluate the 
effect of the matrix. Results of the validation-experiments are depicted in table 1. Maximum 
error observed was 18% for urine 10. To assess the reproducibility, 10 different urines, spiked 
at different levels, were extracted and analysed on 3 consecutive days. Also these results were 
satisfying (Table 2). In both table 1 and 2 a negative deviation (underestimation of the 
concentration) was observed. Therefore the cut-off for the screening method was set to 1.5 
mg/mL, corresponding to the maximum endogenous urinary concentration which was 
previously encountered in blank urines (99.9 percentile of male and female athletes) [18]. 
Using the described screening protocol, a suspicious sample with an estimated concentration 
of 26 mg/mL was detected in a routine batch. The screening –result is presented in figure 1. 
 
Confirmation and interpretation 
For confirmation purposes, multiple (product) ions have to be monitored [31].  These are 
generally obtained by fragmentation of the intact molecule by MS/MS or EI. Because of the 
simplicity of its structure and its poor ionisation behaviour, tandem mass spectrometry does 
not yield usable diagnostic ions for glycerol in LC-MS/MS. Confirmation by LC-MS/MS can 
only be done after derivatization of the glycerol [32,33]. Therefore an in house GC-EI-MS 
confirmation method was developed based on previous work [13,19-22] showing both good 
ionization and acceptable fragmentation. Quantitative confirmatory analysis of the suspicious 
sample by GC-MS showed a final concentration of 12.6 mg/mL, which is greater than the DL. 
Additionally, the mass spectrum fulfilled the criteria as described by WADA taking into 
account 3 diagnostic ions [31]. In figure 2, the extracted chromatograms for a blank urine, 
QC-sample (4.3 mg/mL) and the positive finding are presented.  
Finally, the sample was reported as an AAF to NADO-Flanders. Several possible sources for 
the AAF were considered. Because the sport was kick-boxing, an attempt to manipulate 
blood-parameters [15] was unlikely. Glycerol is also used as a lubricant for self–
catheterization in particular by impaired athletes suffering from neurogenic bladder 
dysfunction [34] Because the sample was obtained from a non-impaired athlete this latter 
possibility could be excluded. The only remaining explanation was that the athlete tried to 
hyper hydrate [9]. However, during the hearing for the disciplinary commission, the athlete 
declared to have used glycerol by drinking 1/5 diluted aqueous solutions (frequency 
unknown) for several weeks in an attempt to lose weight. This therapy was recommended by 
his pharmacist. Indeed, Glycerol can dehydrate a small portion of the body when applied local  
(brain, ear) [3]. However, proof for a systemic dehydrating effect, could not be found. 
Oppositely, taking into account the ability to retain fluid when glycerol is consumed [35], the 
athlete might have gained weight instead of losing. In conclusion, this work shows that the 
combination of LC-HRMS and GC-MS is a good strategy for screening/confirmation of 
glycerol. 
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Table 1: Evaluation of the matrix effect for the LC-HRMS-screening of glycerol, using the 
described sample preparation. 
Blank Spike 
Sample C (µg/mL) C (µg/mL) Error (%)* 
H2O 0,01 3,00 0,0 
urine1 0,01 2,85 -5,0 
urine2 0,02 2,56 -14,5 
urine3 0,02 2,79 -7,0 
urine4 0,02 2,60 -13,2 
urine5 0,02 2,81 -6,3 
urine6 0,02 2,85 -5,0 
urine7 0,01 2,93 -2,3 
urine8 0,02 2,67 -10,8 
urine9 0,01 2,61 -13,0 
urine10 0,01 2,46 -18,0 
*spiked H2O vs urine 
 
 
Table 2: Evaluation of the reproducibility of the LC-HRMS method in 10 spiked urines. The 
average concentration was obtained from 3 extractions and analyses performed on 3 
consecutive days. 
Sample Cspike** Caverage** bias (%) RSD (%) 
urine1 1,5 1,4 -7 14,4 
urine2 5 4,7 -5 5,0 
urine3 7,5 6,6 -12 5,6 
urine4 4 3,6 -9 6,6 
urine5 19 16,8 -11 8,0 
urine6 3 2,9 -5 5,8 
urine7 9 8,5 -5 8,5 
urine8 7 6,3 -10 5,5 
urine9 5 4,8 -5 7,0 
urine10 4 3,9 -2 3,8 
** mg/mL 
 
 
 
 
 
 Figure 1: Extracted chromatograms for glycerol from the screening; (a) Suspicious sample 
(estimated concentration 26 mg/mL), (b) Quality-control sample spiked at 3 mg/mL, (c) blank 
urine sample. 
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Figure 2: Extracted ion chromatograms and corresponding full scan mass spectra for glycerol 
after confirmatory GC-MS analysis: (a) blank sample; (b) QC-sample spiked at 4.3 mg/mL; 
(c) AAF-sample. All chromatograms were scaled to the peak found in the AAF (c) to illustrate 
the low background originating from the endogenous occurrence of glycerol in blank urine 
[13,18,23].   
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